Who we are
The basic mandate of KOEF is to create and effectively implement the Cyprus Drug Verification System (CyMVS), to support all the entities that have the obligation to implement it and to continuously monitor its operation, so as to bring about the desired results. The statutes for the establishment of the KOEF include, among others, actions such as, the organizing of lectures, workshops, seminars, conferences, for training the stakeholders and raising public awareness.
CyMVO acknowledges its responsibility for safety of medicines within Cyprus. Therefore, the CyMVO will ensure the implementation of a national medicines verification system that complies with the Falsified Medicines Directive and the Delegated Regulation. The CyMVO strives to a continuously available and easy-to-use system by improving its quality management processes
Quality objectives are established to implement the quality policy and to continuously improve the quality management system and the quality performance. The following section describes the quality objectives, based on the Quality Policy that was defined. The quality objectives take the goal(s) stated in the Quality Policy and turn these into statements for improvement against which plans can be made.
->A fully operational CyMVS system will be up and running before the 1st of February 2019.
->100% of the national pharmacies and wholesalers on-boarded before the 1st of February 2019.
->Quality System (QMS) will be 100% created, setup and operational before the 1st of February 2019.
->CyMVO personnel are trained in accordance to QMS procedures and policies. The records for all the training programs and the assessments are kept in the personal file of each employee.
->GDPR legislation requirements are defined and implemented across all organization operations.